Cargando…

Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain

The aim of this study was to develop and refine a heterologous mouse model of endometriosis-associated pain in which non-evoked responses, more relevant to the patient experience, were evaluated. Immunodeficient female mice (N = 24) were each implanted with four endometriotic human lesions (N = 12)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tejada, Miguel A., Santos-Llamas, Ana I., Escriva, Lesley, Tarin, Juan J., Cano, Antonio, Fernández-Ramírez, Maria J., Nunez-Badinez, Paulina, De Leo, Bianca, Saunders, Philippa T. K., Vidal, Victor, Barthas, Florent, Vincent, Katy, Sweeney, Patrick J., Sillito, Rowland R., Armstrong, James Douglas, Nagel, Jens, Gomez, Raúl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962432/
https://www.ncbi.nlm.nih.gov/pubmed/35203710
http://dx.doi.org/10.3390/biomedicines10020501
Descripción
Sumario:The aim of this study was to develop and refine a heterologous mouse model of endometriosis-associated pain in which non-evoked responses, more relevant to the patient experience, were evaluated. Immunodeficient female mice (N = 24) were each implanted with four endometriotic human lesions (N = 12) or control tissue fat (N = 12) on the abdominal wall using tissue glue. Evoked pain responses were measured biweekly using von Frey filaments. Non-evoked responses were recorded weekly for 8 weeks using a home cage analysis (HCA). Endpoints were distance traveled, social proximity, time spent in the center vs. outer areas of the cage, drinking, and climbing. Significant differences between groups for von Frey response, climbing, and drinking were detected on days 14, 21, and 35 post implanting surgery, respectively, and sustained for the duration of the experiment. In conclusion, a heterologous mouse model of endometriosis-associated evoked a non-evoked pain was developed to improve the relevance of preclinical models to patient experience as a platform for drug testing.